Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
News
NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of…
GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); September 26, 2023 – GENFIT (Nasdaq and…
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) — Morphic Holdings Inc. (Nasdaq: MORF) today announced that…
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract…
Senti Bio to Participate in Upcoming Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
Adverum Biotechnologies Announces Positive Aflibercept Protein Level Data from the LUNA Phase 2 Trial
Aqueous Aflibercept Protein Expression Levels in LUNA and OPTIC Trials Aqueous aflibercept protein expression levels…
NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
Data presented at the 2023 Cambridge Health Tech Institute’s 2nd Annual Neurodegeneration Targets Conference in…
HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Galecto Announces Plans to Explore Strategic Alternatives
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Gracell Biotechnologies Doses First Patient in Phase 1b/2 Clinical Trial in U.S. Evaluating GC012F for Treatment of Relapsed/Refractory Multiple Myeloma
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 26, 2023 (GLOBE NEWSWIRE) — Gracell…
Goldmoney Inc. Announces Sale of Schiff Gold LLC and Intention to Cancel Securities
Toronto, Ontario–(Newsfile Corp. – September 26, 2023) – Goldmoney Inc. (TSX: XAU) (US: XAUMF) (“Goldmoney”…
Hillcrest Announces Update to Previously Announced Financing
Vancouver, British Columbia–(Newsfile Corp. – September 26, 2023) – Hillcrest Energy Technologies (CSE: HEAT) (FSE:…
Tenet Fintech Group Inc. Files Special Meeting Materials
Toronto, Ontario–(Newsfile Corp. – September 26, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
RIWI Announces Ken Gaalswyk as the New Head of International Development Segment and Change of Auditors
Toronto, Ontario–(Newsfile Corp. – September 26, 2023) – RIWI Corp. (TSXV: RIWI) (OTC Pink: RWCRF)…
Soluna Project Dorothy 1 Reaches Full Capacity of 50 MW, Company hits 2.6 EH/s Hashrate Milestone
Provides Operational Update and Curtailed Energy Consumption Achievement ALBANY, N.Y.–(BUSINESS WIRE)–Soluna Holdings, Inc. (“SHI” or…
American BioCarbon Achieves Commercial Pre-certification with Puro.earth
Company’s first commercial facility is slated to be among largest producers of carbon credits in…
PGT Innovations Announces Participation in Deutsche Bank’s 31st Annual Leveraged Finance Conference
NORTH VENICE, Fla.–(BUSINESS WIRE)–PGT Innovations (NYSE: PGTI), a national leader in the premium window, door,…
Seven Hills Realty Trust Appoints Fernando Diaz Chief Financial Officer and Treasurer
NEWTON, Mass.–(BUSINESS WIRE)–Seven Hills Realty Trust (Nasdaq: SEVN) today announced the appointment of Fernando Diaz,…
Introducing WEVO Pulse, an AI-based UX analysis tool that delivers instant user insights 100 times faster than existing tools
WEVO Pulse provides product, marketing, and design teams feedback in cases they never had time…